A patient receiving fludarabine suddenly develops progressive confusion and shortness of breath. What is the nurse’s priority action?

A client with primary open-angle glaucoma has been using latanoprost ophthalmic solution for the past 4 months. During a follow-up appointment, the client states, “I’ve noticed my eyes look darker than they used to.” The nurse reviews the client’s medication history and recent intraocular pressure readings, which show improvement. Which response by the nurse demonstrates the most accurate clinical understanding of this medication’s pharmacologic effect?

A nurse is reviewing labs for a patient receiving gemcitabine. Which finding requires immediate follow-up?

A patient receiving irinotecan develops severe diarrhea and abdominal cramping during infusion. What is the nurse’s priority intervention?

A nurse is evaluating laboratory results for a client who received myelosuppressive chemotherapy 5 days ago and is currently receiving filgrastim to prevent neutropenic complications. Which laboratory trend indicates the medication is producing the most appropriate therapeutic response?

A client with severe rheumatoid arthritis has been receiving anakinra therapy for several months. During a follow-up visit, the nurse reviews the client’s clinical findings and laboratory data to monitor for immunosuppressive and inflammatory complications associated with this biologic agent. Which findings should the nurse recognize as potential adverse effects related to anakinra therapy? (Select all that apply.)

A nurse is caring for a client who recently underwent a renal transplant and is receiving cyclosporine as part of the immunosuppressive regimen. The nurse is reviewing the patient’s clinical status and laboratory data to monitor for drug-related toxicities. Which findings should the nurse recognize as expected adverse effects associated with cyclosporine therapy? (Select all that apply.)

A client with non-Hodgkin lymphoma has been receiving rituximab therapy for several treatment cycles. During a routine evaluation, the nurse reviews the client’s complete blood count with differential and metabolic panel to assess for therapy-related complications. Which laboratory finding requires immediate follow-up by the nurse due to the risk of life-threatening complications associated with rituximab?

A substance that can intensify or deepen the response of a specimen to a stain is called a(n) __________.

The Snellen letter chart is commonly used to test for __________.